NORDIC PHARMA INC AS

9107 KVALØYA

Finances

Share Ownership

Return on Equity

12,6 %

Current Ratio

5,54

Debt-to-Equity Ratio

0,63

Key figures (NOK)	2022	2021	2020	2019
Revenue	199 015 000	176 563 000	202 357 000	148 237 000
Net Income	33 013 000	39 624 000	50 305 000	21 274 000
Total Assets	455 527 000	419 789 000	383 824 000	323 414 000
Total Equity	262 051 000	229 038 000	189 413 000	139 108 000

Income (NOK)	2022	2021	2020	2019
Revenue	199 015 000	176 563 000	202 357 000	148 237 000
Expenditure	149 036 000	123 933 000	139 671 000	113 674 000
Operating Profit	49 979 000	52 629 000	62 687 000	34 563 000
Financial Income	37 000 000	21 888 000	9 615 000	7 385 000
Financial Costs	44 654 000	23 709 000	7 808 000	14 673 000
Financial Balance	−7 654 000	−1 821 000	1 807 000	−7 288 000
Earnings Before Tax	42 325 000	50 808 000	64 494 000	27 275 000
Tax	9 312 000	11 184 000	14 189 000	6 001 000
Net Income	33 013 000	39 624 000	50 305 000	21 274 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	298 407 000	291 408 000	266 259 000	246 096 000
Total Current Assets	157 119 000	128 382 000	117 565 000	77 318 000
Total Assets	455 527 000	419 789 000	383 824 000	323 414 000
Total Retained Equity	169 007 000	135 994 000	96 369 000	46 064 000
Total Equity	262 051 000	229 038 000	189 413 000	139 108 000
Total Long-Term Debt	165 128 000	134 639 000	146 720 000	159 267 000
Total Current Debt	28 348 000	56 113 000	47 690 000	25 038 000
Total Equity and Debt	455 527 000	419 789 000	383 824 000	323 414 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	196 244 000	175 020 000	201 910 000	147 813 000
Other Income	2 771 000	1 543 000	447 000	423 000
Revenue	199 015 000	176 563 000	202 357 000	148 237 000
Cost of Goods Sold	73 920 000	64 534 000	82 865 000	61 790 000
Salary Costs	29 866 000	19 834 000	22 673 000	21 187 000
Depreciation	22 135 000	19 230 000	17 898 000	15 113 000
Impairment	0	0	0	0
Expenditure	149 036 000	123 933 000	139 671 000	113 674 000
Operating Profit	49 979 000	52 629 000	62 687 000	34 563 000
Financial Income	37 000 000	21 888 000	9 615 000	7 385 000
Financial Costs	44 654 000	23 709 000	7 808 000	14 673 000
Financial Balance	−7 654 000	−1 821 000	1 807 000	−7 288 000
Dividends	0	0	0	0
Net Income	33 013 000	39 624 000	50 305 000	21 274 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	7 987 000
Total Intangible Assets	12 543 000	10 932 000	9 794 000	8 597 000
Real Eastate	63 493 000	65 278 000	54 770 000	57 225 000
Machinery and Plant Facilities	219 209 000	213 372 000	200 540 000	178 669 000
Fixtures	3 162 000	1 825 000	1 155 000	1 605 000
Total Tangible Assets	285 864 000	280 475 000	256 464 000	237 499 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	298 407 000	291 408 000	266 259 000	246 096 000
Stock	83 765 000	48 540 000	36 737 000	41 663 000
Total Investments	0	0	0	0
Cash, Bank	52 634 000	48 926 000	63 441 000	27 362 000
Total Current Assets	157 119 000	128 382 000	117 565 000	77 318 000
Total Assets	455 527 000	419 789 000	383 824 000	323 414 000
Total Equity	262 051 000	229 038 000	189 413 000	139 108 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	165 128 000	134 639 000	146 720 000	159 267 000
Creditors	10 405 000	12 392 000	13 045 000	12 598 000
Unpaid Taxes	1 742 000	1 802 000	1 516 000	1 194 000
Dividends	0	0	0	0
Other Current Debt	5 212 000	3 812 000	17 675 000	4 437 000
Total Current Debt	28 348 000	56 113 000	47 690 000	25 038 000
Total Equity and Debt	455 527 000	419 789 000	383 824 000	323 414 000

Financial indicators	2022	2021	2020	2019
Return on Equity	12,6 %	17,3 %	26,56 %	15,29 %
Debt-to-Equity Ratio	0,63	0,59	0,77	1,14
Operating Profit Margin	25,11 %	29,81 %	30,98 %	23,32 %
Current Ratio	5,54	2,29	2,47	3,09
Quick Ratio	−2,84	16,95	10,73	−4,65
Equity Ratio	0,58	0,55	0,49	0,43
Gross Profit Margin	62,86 %	63,45 %	59,05 %	58,32 %